News | June 01, 2021
Jubilant to invest US $92 mn to expand sterile injectable capacity
This investment is being made to set up a high speed 400 vials a minute injectable fill line with isolator technology
This investment is being made to set up a high speed 400 vials a minute injectable fill line with isolator technology
We focused on developing the product last year but now our focus is on ramping up our manufacturing capacity
The country has constantly worked with the spirit of public-private partnership
Academia-industry partnership to promote indigenous technology commercialization in biotech sector
Expands manufacturing push & locks in major growth deals
The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities
Initiative aims to strengthen South-South collaboration and capacity building in biomedical research
The biosimilars business generated Rs. 10,431 crore in FY26 revenue, up 16% year-on-year
Former DCGI and now advisor to UP CM highlights medical device growth, healthcare expansion, and investment opportunities in the state
With robust FY26 growth, plans AI-led diagnostics and genomic testing expansion
Subscribe To Our Newsletter & Stay Updated
